UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psoriasis and Multiple Sclerosis: Is There a Link?

Journal of Cutaneous Medicine and Surgery, 2010-07, Vol.14 (4), p.151-155

2010

Volltextzugriff (PDF)

Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis

Journal of drugs in dermatology, 2022-10, Vol.21 (10), p.1091-1097

2022

Volltextzugriff (PDF)

Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Dermatology and therapy, 2024-02, Vol.14 (2), p.489-504

2024

Volltextzugriff (PDF)

Management of autoimmune skin disorders in the elderly

Drugs & aging, 2004-01, Vol.21 (12), p.767-777

2004

Volltextzugriff (PDF)

The Coexistence of Psoriasis and Vitiligo: A review

Journal of Cutaneous Medicine and Surgery, 2012-09, Vol.16 (5), p.300-305

2012

Volltextzugriff (PDF)

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

The New England journal of medicine, 2021-03, Vol.384 (12), p.1101-1112

2021

Volltextzugriff (PDF)

354 Genital involvement in patients with atopic dermatitis is associated with sexual difficulties and higher disease burden: results from a real-world multicountry cohort study (MEASURE-AD)

British journal of dermatology (1951), 2023-01, Vol.188 (Supplement_2)

2023

Volltextzugriff (PDF)

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

The New England journal of medicine, 2020-07, Vol.383 (3), p.229-239

2020

Volltextzugriff (PDF)

26834 Secukinumab demonstrated sustained effectiveness in moderate-to-severe plaque psoriasis across weight categories: 36-month data from PURE

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB117-AB117

2021

Volltextzugriff (PDF)

18257 Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB95-AB95

2020

Volltextzugriff (PDF)

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

EClinicalMedicine, 2023-03, Vol.57, p.101826-101826, Article 101826

2023

Volltextzugriff (PDF)

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial

Journal of the American Academy of Dermatology, 2024-08, Vol.91 (2), p.273-280

2024

Volltextzugriff (PDF)

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Journal of cutaneous medicine and surgery, 2023-01, Vol.27 (1_suppl), p.3S-24S

2023

Volltextzugriff (PDF)

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyResearch in context

EClinicalMedicine, 2023-03, Vol.57, p.101826

2023

Volltextzugriff (PDF)

Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

Skin (Milwood, N.Y.), 2021-11, Vol.5 (6), p.s44

2021

Volltextzugriff (PDF)

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

Skin (Milwood, N.Y.), 2021-11, Vol.5 (6), p.s41

2021

Volltextzugriff (PDF)

Case 2

Clinical and experimental dermatology, 2003-09, Vol.28 (5), p.567-568

2003

Volltextzugriff (PDF)

Clinical management where medicine meets management. More than skin deep

The Health service journal, 2004-10, Vol.114 (5928), p.24

2004

Volltextzugriff (PDF)

Efficacy and Safety of Vixarelimab, a Human Monoclonal Oncostatin M Receptor Beta Antibody, in Moderate-to-Severe Prurigo Nodularis: A Randomised, Double-Blind, Placebo-Controlled Phase 2a Study

SSRN Electronic Journal

Volltextzugriff (PDF)

EP1198: EFFICACY AND SAFETY OF ADDING RIBAVIRIN FOR GENOTYPE 3 HCV COMPENSATED CIRRHOSIS RECEIVING 12-WEEKS OF SOFOSBUVIR/VELPATASVIR: A META-ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1281

2022

Volltextzugriff (PDF)

A model‐driven approach towards rational microbial bioprocess optimization

Biotechnology and bioengineering, 2021-01, Vol.118 (1), p.305-318

2021

Volltextzugriff (PDF)

DNA metabarcoding unravels unknown diversity and distribution patterns of tropical freshwater invertebrates

Freshwater biology, 2022-08, Vol.67 (8), p.1411-1427

2022

Volltextzugriff (PDF)

Prophylactic antibiotics in patients with alcohol‐associated hepatitis receiving steroids: A systematic review and meta‐analysis

Liver international, 2024-09, Vol.44 (9), p.2469-2476

2024

Volltextzugriff (PDF)

Mo1499 CLINICAL OUTCOMES OF ALCOHOL-ASSOCIATED HEPATITIS PATIENTS RECEIVING PROPHYLACTIC ANTIBIOTIC VERSUS STANDARD MEDICAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1670-S-1670

2024

Volltextzugriff (PDF)

1060 EPIDEMIOLOGY, NATURAL HISTORY, AND TREATMENT OUTCOMES OF PREGNANT WOMEN WITH HCV INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 227 STUDIES AND 255,862,858 WOMEN

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1564-S-1565

2024

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(46)

Sprache

Englisch
(43)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Psoriasis and Multiple Sclerosis: Is There a Link?

Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis

Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Management of autoimmune skin disorders in the elderly

The Coexistence of Psoriasis and Vitiligo: A review

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

354 Genital involvement in patients with atopic dermatitis is associated with sexual difficulties and higher disease burden: results from a real-world multicountry cohort study (MEASURE-AD)

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

26834 Secukinumab demonstrated sustained effectiveness in moderate-to-severe plaque psoriasis across weight categories: 36-month data from PURE

18257 Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyResearch in context

Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

Case 2

Clinical management where medicine meets management. More than skin deep

Efficacy and Safety of Vixarelimab, a Human Monoclonal Oncostatin M Receptor Beta Antibody, in Moderate-to-Severe Prurigo Nodularis: A Randomised, Double-Blind, Placebo-Controlled Phase 2a Study

EP1198: EFFICACY AND SAFETY OF ADDING RIBAVIRIN FOR GENOTYPE 3 HCV COMPENSATED CIRRHOSIS RECEIVING 12-WEEKS OF SOFOSBUVIR/VELPATASVIR: A META-ANALYSIS

A model‐driven approach towards rational microbial bioprocess optimization

DNA metabarcoding unravels unknown diversity and distribution patterns of tropical freshwater invertebrates

Prophylactic antibiotics in patients with alcohol‐associated hepatitis receiving steroids: A systematic review and meta‐analysis

Mo1499 CLINICAL OUTCOMES OF ALCOHOL-ASSOCIATED HEPATITIS PATIENTS RECEIVING PROPHYLACTIC ANTIBIOTIC VERSUS STANDARD MEDICAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

1060 EPIDEMIOLOGY, NATURAL HISTORY, AND TREATMENT OUTCOMES OF PREGNANT WOMEN WITH HCV INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 227 STUDIES AND 255,862,858 WOMEN

Suchergebnisse filtern